RecruitingNot ApplicableNCT07224204

Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers

Life at 100.4: An Immersive Social Virtual Reality Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers


Sponsor

Yale University

Enrollment

45 participants

Start Date

Feb 11, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.


Eligibility

Min Age: 13 YearsMax Age: 39 Years

Inclusion Criteria2

  • Newly diagnosed with a malignancy or bone marrow failure condition
  • Planned to receive chemotherapy and receive a central line

Exclusion Criteria2

  • Medical contraindication to virtual reality including head wounds and history of seizure with flashing lights
  • No plan to receive chemotherapy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALLife at 100.4

An Immersive Social Virtual Reality Education Tool, participation up to 2 hours


Locations(1)

Pediatric Hematology/Oncology Clinic in Smilow Cancer Hospital

New Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07224204


Related Trials